Jupiter Neurosciences, Inc. Jupiter Neurosciences, Inc.

Jupiter Neurosciences, Inc.

JUNS

Rank in Stocks #32856
Jupiter Neurosciences, Inc. is a pharmaceutical company engaged in... Jupiter Neurosciences, Inc. is a pharmaceutical company engaged in clinical-stage research and development. Its primary focus is on advancing a resveratrol-based platform product, with the main objective of addressing neuro-inflammation. The company's pipeline includes several drug candidates: JNS101 is undergoing Phase II trials for Friedreich's Ataxia, a rare neurological disorder that damages the nervous system and causes mobility issues. Also in Phase II, JNS102 is being developed for mucopolysaccharidosis Type I, JNS107 for MELAS Syndrome, and JNS108 for mild cognitive impairment and early Alzheimer's disease. Furthermore, the company is progressing JNS109 for amyotrophic lateral sclerosis, JNS110 for traumatic brain injury and concussion, and JNS120 as a treatment for COVID-19. Founded in 2016, the company, formerly known as Jupiter Orphan Therapeutics, Inc., adopted its current name in August 2021 and is headquartered in Jupiter, Florida.
Share Price
$1.86
Last synced: 2026-11-12
Market Cap
$1.04M
Change (1 day)
-13.08%
Change (1 year)
48.80%
Country

Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this

Trade Jupiter Neurosciences, Inc. (JUNS)

Category

Healthcare
EPS for Jupiter Neurosciences, Inc. (JUNS)
EPS as of June 2026 TTM: $-19.33
According to Jupiter Neurosciences, Inc.'s latest financial reports, its current EPS (TTM) is $-19.33. At the end of 2025 the company had an EPS of $-18.75, a decrease compared to its 2024 EPS of $-6.36.
EPS history for Jupiter Neurosciences, Inc. from 2019 to 2026
EPS at the end of each year
Year EPS Change
2026 (TTM) $-19.33 3.09%
2025 $-18.75 194.81%
2024 $-6.36 -39.43%
2023 $-10.50 -6.67%
2022 $-11.25 -65.91%
2021 $-33.00 131.58%
2020 $-14.25 -45.71%
2019 $-26.25 0.00%
EPS for similar companies or competitors
Company EPS EPS Difference Country
$-0.89 -95.40%
US
$15.66 -181.01%
US
$-7.07 -63.42%
US
$-5.29 -72.63%
AU
$12.73 -165.87%
BE

Questions about Jupiter Neurosciences, Inc.'s earnings per share (EPS)

What is Jupiter Neurosciences, Inc.'s earnings per share (EPS)?

Jupiter Neurosciences, Inc.'s earnings per share (EPS) over the last twelve months is $-19.33, as of Jun 2026.

What was Jupiter Neurosciences, Inc.'s earnings per share (EPS) in 2025?

In 2025, Jupiter Neurosciences, Inc.'s earnings per share (EPS) was $-18.75, compared with $-6.36 in 2024.

How has Jupiter Neurosciences, Inc.'s earnings per share (EPS) changed since 2020?

From 2020 to 2025, Jupiter Neurosciences, Inc.'s earnings per share (EPS) was highest in 2024 ($-6.36) and lowest in 2021 ($-33.00).

How does Jupiter Neurosciences, Inc.'s earnings per share (EPS) compare with similar companies?

Jupiter Neurosciences, Inc.'s earnings per share (EPS) ($-19.33) is lower than that of all 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with $15.66.